OB Pharma is developing new molecules for the treatment of epilepsy and other seizure related disorders.
Our laboratory is located at the University of Western Ontario’s Robarts Research Institute.
Our late cofounder and CSO, Dr. Michael Poulter was a preeminent neuroscientist and expert in the field of epilepsy research.
OB Pharma is currently seeking venture partners to complete its preclinical program in order to file an IND with the U.S. FDA and a CTA with Health Canada and initiate clinical trials.
If you are an individual or corporate investor, and you are interested in learning more about our development program, please contact us.